Slevin ML - Search Results

1

Phase II study of vinblastine and bleomycin in advanced ovarian cancer.

Osborne RJ, Harvey VJ, Slevin ML, Shepherd JH, Williams CJ. Osborne RJ, et al. Among authors: slevin ml. Cancer Treat Rep. 1987 Mar;71(3):335-6. Cancer Treat Rep. 1987. PMID: 2434227 No abstract available.

2

Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.

Mitchell PL, Al-Nasiri N, A'Hern R, Fisher C, Horwich A, Pinkerton CR, Shepherd JH, Gallagher C, Slevin M, Harper P, Osborne R, Mansi J, Oliver T, Gore ME. Mitchell PL, et al. Cancer. 1999 May 15;85(10):2232-44. doi: 10.1002/(sici)1097-0142(19990515)85:10<2232::aid-cncr19>3.0.co;2-4. Cancer. 1999. PMID: 10326703

3

The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.

Thompson P, Wilson P, Osborne R, Slevin M, Wiltshaw F, Blake P, Harper P, Coleman R, Williams C, Sweetenham J, et al. Thompson P, et al. Br J Cancer. 1991 Nov;64(5):973-4. doi: 10.1038/bjc.1991.440. Br J Cancer. 1991. PMID: 1834157 Free PMC article. Clinical Trial. No abstract available.

4

Phase II trial of UFT in advanced colorectal and gastric cancer.

Malik ST, Talbot D, Clarke PI, Osborne R, Reznek R, Wrigley PF, Slevin ML. Malik ST, et al. Among authors: slevin ml. Br J Cancer. 1990 Dec;62(6):1023-5. doi: 10.1038/bjc.1990.431. Br J Cancer. 1990. PMID: 2257207 Free PMC article.

5

High-dose cytarabine in small cell lung cancer.

Osborne RJ, Clark PI, Slevin ML, Wrigley PF. Osborne RJ, et al. Among authors: slevin ml. Cancer Treat Rep. 1987 Apr;71(4):417-8. Cancer Treat Rep. 1987. PMID: 3030547 Clinical Trial. No abstract available.

6

Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule.

Osborne RJ, Malik ST, Slevin ML, Harvey VJ, Spona J, Salzer H, Williams CJ. Osborne RJ, et al. Among authors: slevin ml. Br J Cancer. 1988 Jan;57(1):115-6. doi: 10.1038/bjc.1988.22. Br J Cancer. 1988. PMID: 3348944 Free PMC article. No abstract available.

7

A phase II study of tamoxifen in ovarian cancer.

Slevin ML, Harvey VJ, Osborne RJ, Shepherd JH, Williams CJ, Mead GM. Slevin ML, et al. Eur J Cancer Clin Oncol. 1986 Mar;22(3):309-12. doi: 10.1016/0277-5379(86)90396-2. Eur J Cancer Clin Oncol. 1986. PMID: 3709599

8

Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

Williams CJ, Mead GM, Macbeth FR, Thompson J, Whitehouse JM, MacDonald H, Harvey VJ, Slevin ML, Lister TA, Shepherd JH, et al. Williams CJ, et al. Among authors: slevin ml. J Clin Oncol. 1985 Nov;3(11):1455-62. doi: 10.1200/JCO.1985.3.11.1455. J Clin Oncol. 1985. PMID: 3903062 Clinical Trial.

9

High-dose cyclophosphamide followed by cisplatinum in the treatment of ovarian cancer.

Osborne R, Evans B, Gallagher C, Wood C, Slevin M, Shepherd J, Wiltshaw E. Osborne R, et al. Cancer Chemother Pharmacol. 1987;20(1):48-52. doi: 10.1007/BF00252959. Cancer Chemother Pharmacol. 1987. PMID: 3621453

10

The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide.

Harvey VJ, Slevin ML, Joel SP, Johnston A, Wrigley PF. Harvey VJ, et al. Among authors: slevin ml. Br J Cancer. 1985 Sep;52(3):363-7. doi: 10.1038/bjc.1985.202. Br J Cancer. 1985. PMID: 2994705 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters